Trending

Joint Pain Injection Market to Grow at a CAGR of 8.5% to reach US$ 6,996.88 million from 2020 to 2028

Joint Pain Injection Market

The joint pain injection market is expected to reach US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% during 2021–2028.

Joint pain injections provide faster relief from severe pain and reduce inflammation of joints. Several types of injections available in the market include corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections, and placental tissue matrix (PTM) injections. The growth of the joint pain injection market is attributed to the factors such as high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, high costs of joint repair therapies hinder the market growth

Download sample Report Copy @ https://www.theinsightpartners.com/sample/TIPRE00003536/

Top Market Players

Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx are among the leading companies operating in the joint pain injection market.

Musculoskeletal disorders are medical conditions affecting muscles, bones, and joints of neck, shoulders, wrists, back, hips, legs, knees, and feet. These diseases include tendinitis, carpal tunnel syndrome, osteoarthritis, rheumatoid arthritis (RA), fibromyalgia, and bone fractures. As per the World Health Organization (WHO) factsheet updated in 2018, musculoskeletal conditions are the second-largest contributor to disability worldwide. According to the same, the prevalence and impact of musculoskeletal disorders is expected to rise with the increase in aging population and rise in the prevalence of risk factors of noncommunicable diseases (NCDs) worldwide. As per 2016 American Academy of Orthopedic Surgeons’ annual meeting data, ~1 in 2 adults is suffering from a musculoskeletal disorder in the US. Further, according to the Centers for Disease Control and Prevention (CDC), arthritis causes severe pain that affects millions of people in the US every year. Around one in four arthritis patients, i.e., ~15 million of total ~54 million patients, experiences severe arthritis-related joint pain.

Further, osteoarthritis (OA) is one of the most common joint disorders in the US, caused by the breakdown of joint cartilage between bones. It is also known as degenerative joint disease or “wear and tear” arthritis. As per the Centers for Disease Control and Prevention (CDC), more than 32.5 million adults in the US suffer from osteoarthritis. Similarly, as per the National Health Service (NHS), more than 10 million people in the UK have arthritis or other similar conditions that affect joints. As per the Bupa Health Insurance, osteoarthritis is the most common form of arthritis prevalent in the UK, it affects around the one-third of people aged 45 or more in the country, i.e., ~8.75 million people. Therefore, such high prevalence of musculoskeletal disorders in different countries is increasing the number of treatment procedures being carried out for the same, thereby driving the joint pain injection market growth.

The report segments the joint pain injection market as follows:

By Drug

  • Hyaluronic Acid
  • Corticosteroid
  • Others

By Joint Type

  • Knee
  • Foot and Ankle
  • Shoulder and Elbow
  • Hip
  • Others

By Distribution Channel

  • Retail Pharmacies
  • Hospitals Pharmacies
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Major questions addressed through this global research report:

  1. What are the demanding sectors for driving this global Joint Pain Injection market?
  2. Which are the major key players and competitors?
  3. What will be the market size of the global market?
  4. Which are the recent advancements in the global Joint Pain Injection market?
  5. What are the restraints, threats, and challenges in front of the market?
  6. What are the global opportunities in front of the market?
  7. How digital footprint helps to expand the business structure and economic outcomes?

Table of Content (TOC):

Chapter 1 Introduction and Overview

Chapter 2 Industry Cost Structure and Economic Impact

Chapter 3 Rising Trends and New Technologies with Major key players

Chapter 4 Global Joint Pain Injection Market Analysis, Trends, Growth Factor

Chapter 5 Joint Pain Injection Market Application and Business with Potential Analysis

Chapter 6 Global Joint Pain Injection Market Segment, Type, Application

Chapter 7 Global Joint Pain Injection Market Analysis (by Application, Type, End User)

Chapter 8 Major Key Vendors Analysis of Joint Pain Injection Market

Chapter 9 Development Trend of Analysis

Chapter 10 Conclusion

Purchase Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00003536/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defence.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

Related Articles

Back to top button